Ignite Creation Date:
2024-05-06 @ 7:47 PM
Last Modification Date:
2024-10-26 @ 3:13 PM
Study NCT ID:
NCT06130254
Status:
RECRUITING
Last Update Posted:
2024-04-16
First Post:
2023-11-08
Brief Title:
Phase Ib Trial of the KRAS G12C Inhibitor Adagrasib MRTX849 in Combination With the PARP Inhibitor Olaparib in Patients With KRAS G12C Mutated Advanced Solid Tumors With a Focus on Gynecological Breast Pancreatic and KEAP1 Mutated Non-small Cell Lung Cancers
Sponsor:
Organization:
MD Anderson Cancer Center